OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 ↓ (860) 240-0200
AN ACT CONCERNING ULTRASOUND PROCEDURES FOR MEDICAL AND DIAGNOSTIC PURPOSES.
LCO No.: 6577
File Copy No.: 367
House Calendar No.: 260
Senate Calendar No.: 600
OFA Fiscal Note
This amendment requires each institution caring for newborn infants to test each child for severe combined immunodeficiency (SCID) as soon after birth as medically appropriate.
The University of Connecticut Health Center (UCHC) has approximately 600 births annually. UCHC would incur additional costs for testing each child after birth. However, it is assumed that these costs would be recouped through third party billing.
The state Medicaid program pays for approximately 12, 000 births annually. Based on a program implemented in Wisconsin, it is estimated that each screen costs approximately $75. Therefore, the state would incur an estimated annual cost of $900, 000. The same study in Wisconsin indicated that SCID babies that are undiagnosed or diagnosed late cost $1 million to $2 million to treat. Therefore, to the extent that these enhanced screens allow early treatment (via bone marrow transplant at a cost of approximately $170, 000 per treatment) and the avoidance of ongoing SCID costs, state Medicaid costs may be reduced.
The estimated prevalence of SCID is 1 in 66, 000 births.
Sources: Wisconsin Department of Health and Family Services, Kaiser State Health Facts
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely for the purposes of information, summarization and explanation and does not represent the intent of the General Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of informational sources, including the analyst's professional knowledge. Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.